| The concise guide to pharmacology 2021/22: Enzymes SPH Alexander, D Fabbro, E Kelly, A Mathie, JA Peters, EL Veale, ... British journal of pharmacology 178, S313-S411, 2021 | 381 | 2021 |
| Hypersensitivity to very-low single radiation doses: its relationship to the adaptive response and induced radioresistance MC Joiner, P Lambin, EP Malaise, T Robson, JE Arrand, KA Skov, ... Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 358 (2 …, 1996 | 363 | 1996 |
| Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene delivery HO McCarthy, J McCaffrey, CM McCrudden, A Zholobenko, AA Ali, ... Journal of Controlled Release 189, 141-149, 2014 | 236 | 2014 |
| The concise guide to PHARMACOLOGY 2023/24: enzymes SPH Alexander, D Fabbro, E Kelly, AA Mathie, JA Peters, EL Veale, ... British Journal of Pharmacology 180, S289-S373, 2023 | 197 | 2023 |
| Transcriptional targeting in cancer gene therapy T Robson, DG Hirst BioMed Research International 2003 (2), 110-137, 2003 | 173 | 2003 |
| Nitric oxide physiology and pathology DG Hirst, T Robson Nitric Oxide: Methods and Protocols, 1-13, 2010 | 167 | 2010 |
| Relationship between clonogenic radiosensitivity, radiation-induced apoptosis and DNA damage/repair in human colon cancer cells AL Dunne, ME Price, C Mothersill, SR McKeown, T Robson, DG Hirst British journal of cancer 89 (12), 2277-2283, 2003 | 159 | 2003 |
| Targeting nitric oxide for cancer therapy D Hirst, T Robson Journal of Pharmacy and Pharmacology 59 (1), 3-13, 2007 | 141 | 2007 |
| Nitric oxide—a novel therapeutic for cancer JA Coulter, HO McCarthy, J Xiang, W Roedl, E Wagner, T Robson, ... Nitric oxide 19 (2), 192-198, 2008 | 138 | 2008 |
| Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophages JK Dowling, R Afzal, LJ Gearing, MP Cervantes-Silva, S Annett, GM Davis, ... Nature communications 12 (1), 1460, 2021 | 130 | 2021 |
| Top notch targeting strategies in cancer: a detailed overview of recent insights and current perspectives G Moore, S Annett, L McClements, T Robson Cells 9 (6), 1503, 2020 | 119 | 2020 |
| DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles AA Ali, CM McCrudden, J McCaffrey, JW McBride, G Cole, NJ Dunne, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (3), 921-932, 2017 | 117 | 2017 |
| Antitumour prodrug development using cytochrome P450 (CYP) mediated activation. LH Patterson, SR McKeown, T Robson, R Gallagher, SM Raleigh, S Orr Anti-Cancer Drug Design 14 (6), 473-486, 1999 | 117 | 1999 |
| Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy D Hirst, T Robson Current pharmaceutical design 16 (4), 411-420, 2010 | 99 | 2010 |
| DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigen G Cole, AA Ali, E McErlean, EJ Mulholland, A Short, CM McCrudden, ... Acta Biomaterialia 96, 480-490, 2019 | 91 | 2019 |
| Hypoxia selects for androgen independent LNCaP cells with a more malignant geno‐and phenotype KT Butterworth, HO McCarthy, A Devlin, L Ming, T Robson, SR McKeown, ... International Journal of Cancer 123 (4), 760-768, 2008 | 91 | 2008 |
| Overexpression of metallothionein in CHO cells and its effect on cell killing by ionizing radiation and alkylating agents H Lohrer, T Robson Carcinogenesis 10 (12), 2279-2284, 1989 | 89 | 1989 |
| Targeting cancer stem cells in the clinic: Current status and perspectives S Annett, T Robson Pharmacology & therapeutics 187, 13-30, 2018 | 86 | 2018 |
| Nitrosative stress in cancer therapy DG Hirst, T Robson Front Biosci 12, 3406-3418, 2007 | 85 | 2007 |
| DNA vaccination for cervical cancer: Strategic optimisation of RALA mediated gene delivery from a biodegradable microneedle system G Cole, AA Ali, CM McCrudden, JW McBride, J McCaffrey, T Robson, ... European Journal of Pharmaceutics and Biopharmaceutics 127, 288-297, 2018 | 83 | 2018 |